Corcept Therapeutics Incorporated (CORT) — Capital Reinvestment Ratio
Corcept Therapeutics Incorporated (CORT) has a Capital Reinvestment Ratio of 0.00x as of December 2025, meaning it reinvests 0% of its operating cash flow ($38.45 Million) in capital expenditures ($50.00K). Check Corcept Therapeutics Incorporated (CORT) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Corcept Therapeutics Incorporated Capital Reinvestment Ratio (2015–2025)
This chart tracks Corcept Therapeutics Incorporated's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Corcept Therapeutics Incorporated.
Annual Capital Reinvestment Ratio for Corcept Therapeutics Incorporated (2015–2025)
Year-by-year Capital Reinvestment Ratio for Corcept Therapeutics Incorporated from 2015 to 2025. See CORT free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | $142.00 Million | $211.00K | ▼ -86.4% |
| 2024 | 0.01x | $198.07 Million | $2.17 Million | ▲ +902.2% |
| 2023 | 0.00x | $127.04 Million | $139.00K | ▼ -68.1% |
| 2022 | 0.00x | $120.32 Million | $413.00K | ▲ +22.9% |
| 2021 | 0.00x | $167.89 Million | $469.00K | ▼ -65.7% |
| 2020 | 0.01x | $151.97 Million | $1.24 Million | ▲ +1.9% |
| 2019 | 0.01x | $136.12 Million | $1.09 Million | ▲ +210.2% |
| 2018 | 0.00x | $115.67 Million | $298.00K | ▼ -62.5% |
| 2017 | 0.01x | $60.94 Million | $419.00K | ▼ -34.8% |
| 2016 | 0.01x | $18.39 Million | $194.00K | ▲ +94.2% |
| 2015 | 0.01x | $3.13 Million | $17.00K | — |